Arctic Bioscience AS (OSL:ABS)

Arctic Bioscience AS Financials Overview

Financials in millions NOK. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	42.62	42.62	44.39	33.75	34.47	21.52
Revenue Growth	-7.12%	-4.00%	31.53%	-2.09%	60.21%	4.48%
Gross Profit Gross Profit Growth	13.56	13.56	15.14	9.77	11.84	5.8
Operating Income Operating Income Growth	-33.45	-33.45	-45.46	-48.59	-34.73	-39.94
Net Income Net Income Growth	-41.03	-41.03	-47.93	-45.51	-34.02	-42.58
Earnings Per Share EPS Growth	-1.52	-1.52	-1.89	-1.79	-1.39	-1.75
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
B2C B2C Growth	4.85	4.85	4.95	4.28	3.49
B2B B2B Growth	35.25	35.25	38.53	29.47	30.78
Total Total Growth	40.1	40.1	43.48	33.75	34.27

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1.29	1.29	3.28	79.6	144.15	227.36
Total Debt Total Debt Growth	62.32	62.32	21.71	2.05	-	0
Net Cash (Debt) Net Cash Growth	-61.03	-61.03	-18.43	77.55	144.15	227.36
Net Cash Growth	-	-	-	-46.20%	-36.60%	5385.57%
Net Cash Per Share Net Cash Per Share Growth	-2.26	-2.26	-0.73	3.05	5.89	9.34

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	-22.65	-22.65	-45.36	-30.37	-25.4	-39.49
Capital Expenditures CapEx Growth	-22.75	-22.75	-50.81	-34.7	-58.57	-36.5
Free Cash Flow Free Cash Flow Growth	-45.4	-45.4	-96.17	-65.07	-83.96	-76
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	31.83%	31.83%	34.10%	28.96%	34.36%	26.95%
Operating Margin	-78.49%	-78.49%	-102.41%	-143.98%	-100.75%	-185.63%
Pretax Margin	-96.27%	-96.27%	-107.98%	-134.86%	-98.71%	-197.90%
Profit Margin	-96.27%	-96.27%	-107.98%	-134.86%	-98.71%	-197.90%
FCF Margin	-106.53%	-106.53%	-216.64%	-192.81%	-243.58%	-353.22%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PS Ratio	1.77	2.08	1.05	7.89	8.35	20.10

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error